The amygdala, a brain structure critical in making judgments, is markedly smaller in cocaine addicts, according to a study conducted at Harvard Medical School. While the results are preliminary, they may indicate that reduced amygdala volumes predispose people to cocaine addiction.
The amygdala, a brain structure critical in making judgments, is markedly smaller in cocaine addicts, according to a study conducted at Harvard Medical School. While the results are preliminary, they may indicate that reduced amygdala volumes predispose people to cocaine addiction.
The amygdala is an almond-shaped structure in the anterior section of the brain's temporal lobe. It allows people to evaluate environmental cues for evidence of danger. The amygdala orchestrates other brain regions to produce appropriate responses in dangerous situations, said Dr. Nickos Makris, an assistant professor of neurology and the study's lead author.
"Subjects who have reduced amygdala volumes, like the cocaine-dependent population in our study, show significant difficulty identifying and judging the potential negative outcomes of their behavior," he said.
Makris and colleagues examined structural MR imaging data from the brains of 27 cocaine addicts and a control group of nonaddicts (Neuron 2004 Nov. 18;44[4]:729-740).
The amygdalas of cocaine-addicted subjects were an average of 13% smaller on the left side of the brain and 23% smaller on the right side, compared with control subjects. Additionally, the amygdalas in the cocaine-dependent subjects showed unequal volumes on the two sides of the brain as opposed to the laterality seen in the amygdalas of the healthy subjects.
Amygdala size did not correlate to measures of anxiety, depression, cocaine use, or age at which cocaine use began. The researchers did not have sufficient evidence to determine whether reduced size resulted from cocaine abuse or predated the abuse.
Family-based or longitudinal studies of illness progression are being developed at the Massachusetts General Hospital NMR Center. They could settle the question of whether the observed decrease in amygdala volume in these subjects represents an early neural marker of cocaine use or a developmental trait that increases the risk of drug dependence, Makris said.
"The results of our study have clear policy implications. If it is proven that genes are to blame, then MRI-based strategies for prediction and prevention measures should be applied," he said.
For more information from the online Diagnostic Imaging archives:
Imaging untangles mystery of drug-addicted brain
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.